DETAILS, FICTION AND WHO MAKES COPYRIGHT SEMAGLUTIDE

In March 2025, the company introduced new options for the immediate-to-consumer presenting of its Wegovy weight loss drug. The company set up a whole new pharmacy, called NovoCare, which might charge shoppers $499 monthly for use of the drug, less than half the expense of the drug by way of other pharmaceutical distribution networks.[53]Novo Nordis